Thorsten Herr,Thomas Hummel,Marcus Vollmer et al.
Thorsten Herr et al.
The pathophysiology of cervical dystonia is not completely understood. Current concepts of the pathophysiology propose that it is a network disorder involving the basal ganglia, cerebellum and sensorimotor cortex. These structures are prima...
Daniela C Rosenberger,Vivian Blechschmidt,Hans Timmerman et al.
Daniela C Rosenberger et al.
Neuropathic pain is a frequent condition caused by a lesion or disease of the central or peripheral somatosensory nervous system. A frequent cause of peripheral neuropathic pain is diabetic neuropathy. Its complex pathophysiology is not yet...
Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease [0.03%]
阿尔茨海默病和帕金森病非转基因动物模型共有的脑代谢病理损害
Jelena Osmanovic Barilar,Ana Knezovic,Ana Babic Perhoc et al.
Jelena Osmanovic Barilar et al.
Parkinson's disease (PD) and Alzheimer's disease (AD) are the most common chronic neurodegenerative disorders, characterized by motoric dysfunction or cognitive decline in the early stage, respectively, but often by both symptoms in the adv...
Parkinson's disease and iron [0.03%]
帕金森病与铁
Hideki Mochizuki,Chi-Jing Choong,Kousuke Baba
Hideki Mochizuki
While the initial causes of Parkinson's disease (PD) are not clearly defined, iron deposition has long been implicated in the pathogenesis of PD. The substantia nigra of PD patients, where the selective loss of dopaminergic neurons occurs, ...
Ekaterina Lazdon,Nofar Stolero,Dan Frenkel
Ekaterina Lazdon
Parkinson's disease (PD) is a neurodegenerative disease associated with motor deficiency and rigidity. The genetic risks of the disease is reported to be between 5 and 10% depending on the background of the population. While PD is not consi...
Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson's disease [0.03%]
多巴胺能刺激后帕金森病患者经治疗者对仪器检测的不同反应及其与认知需求的关系
Thomas Müller,Ali Harati
Thomas Müller
Instrumental measurement of response assets and movement behaviour gained importance as addition to rating procedures to determine the efficacy of therapeutic interventions in patients with Parkinson's disease. Objectives were to determine ...
Rasagiline and selegiline modulate mitochondrial homeostasis, intervene apoptosis system and mitigate α-synuclein cytotoxicity in disease-modifying therapy for Parkinson's disease [0.03%]
rasagiline和selegiline通过调控线粒体稳态，干预凋亡系统，降低α-突触核蛋白毒性治疗帕金森病的作用机制研究
Makoto Naoi,Wakako Maruyama,Masayo Shamoto-Nagai
Makoto Naoi
Parkinson's disease has been considered as a motor neuron disease with dopamine (DA) deficit caused by neuronal loss in the substantia nigra, but now proposed as a multi-system disorder associated with α-synuclein accumulation in neuronal ...
Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson's disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy? [0.03%]
题图：关于帕金森病的心理治疗假说：认知行为疗法(CBT)、接受承诺疗法(ACT)和森田疗法的神经机制？的更正
Toshiharu Nagatsu
Toshiharu Nagatsu
The original version of this article unfortunately contained a mistake. The year in the Acknowledgements section should be "1963" not "1993".
Correction to: Neural and dopaminergic correlates of fatigue in Parkinson's disease [0.03%]
帕金森病患者疲劳的神经和多巴胺能相关因素的更正通知
Suk Yun Kang,Mirim Bang,Jin Yong Hong et al.
Suk Yun Kang et al.